Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumito Ito

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Cancer Research|May 20, 2016
Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological MemoryHidehito Saito, Keisuke Okita, Alfred E Chang, et al.
The Journal of Surgical Research|December 12, 2018
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular CarcinomaToshifumi Hoki, Eriko Katsuta, Li Yan, et al.
Scientific Reports|January 29, 2024
Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanomaTakaaki Oba, Mark D Long, Ken-Ichi Ito, et al.
Cancer Research|October 20, 2021
Neoadjuvant <i>In Situ</i> Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic TumorsTakaaki Oba, Ryutaro Kajihara, Toshihiro Yokoi, et al.
Annals of Surgery|July 30, 2009
Hilar cholangiocarcinoma: current managementFumito Ito, Clifford S Cho, Layton F Rikkers, et al.
Scientific Reports|November 10, 2021
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancerToshihiro Yokoi, Takaaki Oba, Ryutaro Kajihara, et al.
Cancer Research|May 17, 2003
Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapyQiao Li, Abbey Carr, Fumito Ito, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine modelFumito Ito, Abbey Carr, Hakan Svensson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2021
Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 ExpressionAnkit Patel, Takaaki Oba, Ryutaro Kajihara, et al.
Stem Cells International|April 9, 2016
Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem CellsHidehito Saito, Keisuke Okita, Noemi Fusaki, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Cancer Research|May 20, 2016
Adoptive Transfer of CD8+ T Cells Generated from Induced Pluripotent Stem Cells Triggers Regressions of Large Tumors Along with Immunological MemoryHidehito Saito, Keisuke Okita, Alfred E Chang, et al.
The Journal of Surgical Research|December 12, 2018
Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular CarcinomaToshifumi Hoki, Eriko Katsuta, Li Yan, et al.
Scientific Reports|January 29, 2024
Clinical and immunological relevance of SLAMF6 expression in the tumor microenvironment of breast cancer and melanomaTakaaki Oba, Mark D Long, Ken-Ichi Ito, et al.
Cancer Research|October 20, 2021
Neoadjuvant <i>In Situ</i> Immunomodulation Enhances Systemic Antitumor Immunity against Highly Metastatic TumorsTakaaki Oba, Ryutaro Kajihara, Toshihiro Yokoi, et al.
Annals of Surgery|July 30, 2009
Hilar cholangiocarcinoma: current managementFumito Ito, Clifford S Cho, Layton F Rikkers, et al.
Scientific Reports|November 10, 2021
Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancerToshihiro Yokoi, Takaaki Oba, Ryutaro Kajihara, et al.
Cancer Research|May 17, 2003
Polarization effects of 4-1BB during CD28 costimulation in generating tumor-reactive T cells for cancer immunotherapyQiao Li, Abbey Carr, Fumito Ito, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 14, 2003
Antitumor reactivity of anti-CD3/anti-CD28 bead-activated lymphoid cells: implications for cell therapy in a murine modelFumito Ito, Abbey Carr, Hakan Svensson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2021
Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti-PD-L1 Therapy via IRF8 ExpressionAnkit Patel, Takaaki Oba, Ryutaro Kajihara, et al.
Stem Cells International|April 9, 2016
Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem CellsHidehito Saito, Keisuke Okita, Noemi Fusaki, et al.
Pageof 6